Pharmadax Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Pharmadax Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 154.8 million compared to TWD 253.59 million a year ago. Net loss was TWD 167.32 million compared to TWD 125.2 million a year ago. Basic loss per share from continuing operations was TWD 2.36 compared to TWD 1.86 a year ago. Diluted loss per share from continuing operations was TWD 2.36 compared to TWD 1.86 a year ago.